As of August 29, 2026, Lineage Cell Therapeutics's top three insider holders are Partners, L.P. Broadwood (Director, 49.56Mn shares), Michael H. Mulroy (Director, 298.56K shares), Michael H. Mulroy (Director, 258.56K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Partners, L.P. Broadwood | Director, TenPercentOwner | 49,560,992 | 0 | 49,560,992 | 97.6% | 28 Jan, 2025 |
| 2 | Michael H. Mulroy | Director | 557,110 | 0 | 557,110 | 1.1% | 25 Nov, 2024 |
| 3 | Brian M Culley | President And Ceo | 400,358 | 0 | 400,358 | 0.8% | 12 Mar, 2026 |
| 4 | Don M Bailey | Director | 0 | 158,801 | 158,801 | 0.3% | 08 Feb, 2024 |
| 5 | George A. Iii Samuel | General Counsel And Secretary | 38,247 | 0 | 38,247 | 0.1% | 13 Feb, 2026 |
| 6 | Dipti Amin | Director | 35,000 | 0 | 35,000 | 0.1% | 29 Mar, 2022 |
| 7 | Jill Ann Howe | Chief Financial Officer | 25,500 | 0 | 25,500 | 0.1% | 26 Nov, 2024 |
| 8 | Anula Jayasuriya | Director | 10,000 | 0 | 10,000 | 0.0% | 02 Jan, 2024 |
| 9 | Gary S. Hogge | Svp,Clinical Medical Affairs | 7,710 | 0 | 7,710 | 0.0% | 14 Feb, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Jul, 2026 | Deborah J Andrews | Director | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 01 Jul, 2026 | Dipti Amin | Director | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 01 Jul, 2026 | Neal C Bradsher | Director, TenPercentOwner | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 01 Jul, 2026 | Michael H. Mulroy | Director | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 01 Jul, 2026 | Anula Jayasuriya | Director | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 12 Mar, 2026 | Brian M Culley | President And Ceo | Acquired P | 15,000 | $1.63 | $24.38K | 255,516 | Direct |
| 05 Mar, 2026 | Brian M Culley | President And Ceo | Acquired A | 3,250,000 | $0.00 | $0 | 3,250,000 | Direct |
| 05 Mar, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired A | 900,000 | $0.00 | $0 | 900,000 | Direct |
| 05 Mar, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired A | 900,000 | $0.00 | $0 | 900,000 | Direct |
| 05 Mar, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired A | 900,000 | $0.00 | $0 | 900,000 | Direct |
| 05 Mar, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired A | 900,000 | $0.00 | $0 | 900,000 | Direct |
| 05 Mar, 2026 | Jill Ann Howe | Chief Financial Officer | Acquired A | 1,050,000 | $0.00 | $0 | 1,050,000 | Direct |
| 05 Mar, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired A | 900,000 | $0.00 | $0 | 900,000 | Direct |
| 11 Feb, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired M | 6,075 | — | — | 33,565 | Direct |
| 11 Feb, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired M | 6,075 | — | — | 33,565 | Direct |
| 11 Feb, 2026 | Brian M Culley | President And Ceo | Acquired M | 31,250 | — | — | 253,385 | Direct |
| 11 Feb, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired M | 6,075 | — | — | 33,565 | Direct |
| 11 Feb, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired M | 6,075 | — | — | 33,565 | Direct |
| 11 Feb, 2026 | George A. Iii Samuel | General Counsel And Secretary | Acquired M | 6,075 | — | — | 33,565 | Direct |
| 11 Feb, 2026 | George A. Iii Samuel | General Counsel And Secretary | Disposed F | 2,502 | $1.80 | $4.50K | 31,063 | Direct |